BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23744992)

  • 1. Liver-specific cholesteryl ester hydrolase deficiency attenuates sterol elimination in the feces and increases atherosclerosis in ldlr-/- mice.
    Bie J; Wang J; Marqueen KE; Osborne R; Kakiyama G; Korzun W; Ghosh SS; Ghosh S
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1795-802. PubMed ID: 23744992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice.
    Bie J; Wang J; Yuan Q; Kakiyama G; Ghosh SS; Ghosh S
    J Lipid Res; 2014 Apr; 55(4):729-38. PubMed ID: 24563511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation between hepatic cholesteryl ester hydrolase and scavenger receptor BI for hydrolysis of HDL-CE.
    Yuan Q; Bie J; Wang J; Ghosh SS; Ghosh S
    J Lipid Res; 2013 Nov; 54(11):3078-84. PubMed ID: 23990661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic overexpression of cholesteryl ester hydrolase enhances cholesterol elimination and in vivo reverse cholesterol transport.
    Zhao B; Song J; Ghosh S
    J Lipid Res; 2008 Oct; 49(10):2212-7. PubMed ID: 18599737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular cholesterol transport proteins enhance hydrolysis of HDL-CEs and facilitate elimination of cholesterol into bile.
    Wang J; Bie J; Ghosh S
    J Lipid Res; 2016 Sep; 57(9):1712-9. PubMed ID: 27381048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
    Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo.
    Gillard BK; Rodriguez PJ; Fields DW; Raya JL; Lagor WR; Rosales C; Courtney HS; Gotto AM; Pownall HJ
    Biochim Biophys Acta; 2016 Mar; 1861(3):196-204. PubMed ID: 26709142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice.
    Sberna AL; Assem M; Gautier T; Grober J; Guiu B; Jeannin A; Pais de Barros JP; Athias A; Lagrost L; Masson D
    J Hepatol; 2011 Jul; 55(1):154-61. PubMed ID: 21145854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice.
    Wiersma H; Gatti A; Nijstad N; Kuipers F; Tietge UJ
    J Lipid Res; 2009 Aug; 50(8):1571-80. PubMed ID: 19252221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
    Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2006 Nov; 281(44):33053-65. PubMed ID: 16928680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CETP expression enhances liver HDL-cholesteryl ester uptake but does not alter VLDL and biliary lipid secretion.
    Harada LM; Amigo L; Cazita PM; Salerno AG; Rigotti AA; Quintão EC; Oliveira HC
    Atherosclerosis; 2007 Apr; 191(2):313-8. PubMed ID: 16806230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous Determination of Biliary and Intestinal Cholesterol Secretion Reveals That CETP (Cholesteryl Ester Transfer Protein) Alters Elimination Route in Mice.
    Li J; Pijut SS; Wang Y; Ji A; Kaur R; Temel RE; van der Westhuyzen DR; Graf GA
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1986-1995. PubMed ID: 31462090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxylesterase 1d (Ces1d) does not contribute to cholesteryl ester hydrolysis in the liver.
    Lian J; van der Veen JN; Watts R; Jacobs RL; Lehner R
    J Lipid Res; 2021; 62():100093. PubMed ID: 34153284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
    Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel intracellular cholesteryl ester hydrolase (carboxylesterase 3) in human macrophages: compensatory increase in its expression after carboxylesterase 1 silencing.
    Zhao B; Bie J; Wang J; Marqueen SA; Ghosh S
    Am J Physiol Cell Physiol; 2012 Aug; 303(4):C427-35. PubMed ID: 22700792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
    Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice.
    He H; Wang J; Yannie PJ; Kakiyama G; Korzun WJ; Ghosh S
    J Biol Chem; 2018 Jun; 293(24):9223-9231. PubMed ID: 29700117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic NPC1L1 promotes hyperlipidemia in LDL receptor deficient mice.
    Wang Y; Tang W; Yang P; Shin H; Li Q
    Biochem Biophys Res Commun; 2018 May; 499(3):626-633. PubMed ID: 29601818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bolstering cholesteryl ester hydrolysis in liver: A hepatocyte-targeting gene delivery strategy for potential alleviation of atherosclerosis.
    He H; Lancina MG; Wang J; Korzun WJ; Yang H; Ghosh S
    Biomaterials; 2017 Jun; 130():1-13. PubMed ID: 28349866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.